U.S. flag

An official website of the United States government

NC_000023.11:g.(154612552_154656872)_(156005236_156038495)del AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 19, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001839140.1

Allele description [Variation Report for NC_000023.11:g.(154612552_154656872)_(156005236_156038495)del]

NC_000023.11:g.(154612552_154656872)_(156005236_156038495)del

Genes:
  • LOC130068885:ATAC-STARR-seq lymphoblastoid active region 30068 [Gene]
  • LOC130068887:ATAC-STARR-seq lymphoblastoid active region 30069 [Gene]
  • LOC130068889:ATAC-STARR-seq lymphoblastoid active region 30070 [Gene]
  • LOC130068890:ATAC-STARR-seq lymphoblastoid active region 30071 [Gene]
  • LOC130068891:ATAC-STARR-seq lymphoblastoid active region 30072 [Gene]
  • LOC130068892:ATAC-STARR-seq lymphoblastoid active region 30073 [Gene]
  • LOC130068895:ATAC-STARR-seq lymphoblastoid active region 30074 [Gene]
  • LOC130068898:ATAC-STARR-seq lymphoblastoid active region 30078 [Gene]
  • LOC130068882:ATAC-STARR-seq lymphoblastoid silent region 21115 [Gene]
  • LOC130068883:ATAC-STARR-seq lymphoblastoid silent region 21116 [Gene]
  • LOC130068884:ATAC-STARR-seq lymphoblastoid silent region 21117 [Gene]
  • LOC130068886:ATAC-STARR-seq lymphoblastoid silent region 21118 [Gene]
  • LOC130068888:ATAC-STARR-seq lymphoblastoid silent region 21119 [Gene]
  • LOC130068893:ATAC-STARR-seq lymphoblastoid silent region 21120 [Gene]
  • LOC130068894:ATAC-STARR-seq lymphoblastoid silent region 21121 [Gene]
  • LOC130068896:ATAC-STARR-seq lymphoblastoid silent region 21124 [Gene]
  • LOC130068897:ATAC-STARR-seq lymphoblastoid silent region 21125 [Gene]
  • BRCC3:BRCA1/BRCA2-containing complex subunit 3 [Gene - OMIM - HGNC]
  • CMC4:C-X9-C motif containing 4 [Gene - OMIM - HGNC]
  • FUNDC2:FUN14 domain containing 2 [Gene - OMIM - HGNC]
  • GAB3:GRB2 associated binding protein 3 [Gene - OMIM - HGNC]
  • H2AB1:H2A.B variant histone 1 [Gene - OMIM - HGNC]
  • H2AB2:H2A.B variant histone 2 [Gene - OMIM - HGNC]
  • H2AB3:H2A.B variant histone 3 [Gene - OMIM - HGNC]
  • LOC107988024:IKBKGP1 recombination region [Gene]
  • LOC107988025:IKBKGP1 upstream recombination region [Gene]
  • MPP1:MAGUK p55 scaffold protein 1 [Gene - OMIM - HGNC]
  • LOC126863349:P300/CBP strongly-dependent group 1 enhancer GRCh37_chrX:154195537-154196736 [Gene]
  • RAB39B:RAB39B, member RAS oncogene family [Gene - OMIM - HGNC]
  • LOC113875015:Sharpr-MPRA regulatory region 12525 [Gene]
  • LOC125467794:Sharpr-MPRA regulatory region 13577 [Gene]
  • LOC121627986:Sharpr-MPRA regulatory region 3530 [Gene]
  • LOC125467795:Sharpr-MPRA regulatory region 4209 [Gene]
  • LOC113875016:Sharpr-MPRA regulatory region 7862 [Gene]
  • TMLHE-AS1:TMLHE antisense RNA 1 [Gene - HGNC]
  • VBP1:VHL binding protein 1 [Gene - OMIM - HGNC]
  • WASIR1:WASH and IL9R antisense RNA 1 [Gene - HGNC]
  • CTAG1B:cancer/testis antigen 1B [Gene - OMIM - HGNC]
  • CTAG2:cancer/testis antigen 2 [Gene - OMIM - HGNC]
  • CLIC2:chloride intracellular channel 2 [Gene - OMIM - HGNC]
  • F8A1:coagulation factor VIII associated 1 [Gene - OMIM - HGNC]
  • F8A2:coagulation factor VIII associated 2 [Gene - HGNC]
  • F8A3:coagulation factor VIII associated 3 [Gene - HGNC]
  • F8:coagulation factor VIII [Gene - OMIM - HGNC]
  • DKC1:dyskerin pseudouridine synthase 1 [Gene - OMIM - HGNC]
  • FAM223B:family with sequence similarity 223 member B [Gene - HGNC]
  • LOC106146143:int1h-1 recombination region [Gene]
  • LOC106146144:int1h-2 recombination region [Gene]
  • LOC106146150:int22h-1 recombination region [Gene]
  • LOC106146151:int22h-2 recombination region [Gene]
  • LOC106146152:int22h-3 recombination region [Gene]
  • IL9R:interleukin 9 receptor [Gene - OMIM - HGNC]
  • MTCP1:mature T cell proliferation 1 [Gene - OMIM - HGNC]
  • LOC107522039:meiotic recombination hotspot PAR2 [Gene]
  • LOC107838685:meiotic recombination hotspot PAR2A [Gene]
  • MIR1184-1:microRNA 1184-1 [Gene - HGNC]
  • MIR1184-2:microRNA 1184-2 [Gene - HGNC]
  • MIR1184-3:microRNA 1184-3 [Gene - HGNC]
  • MIR664B:microRNA 664b [Gene - HGNC]
  • SMIM9:small integral membrane protein 9 [Gene - HGNC]
  • SNORA36A:small nucleolar RNA, H/ACA box 36A [Gene - HGNC]
  • SNORA56:small nucleolar RNA, H/ACA box 56 [Gene - HGNC]
  • SPRY3:sprouty RTK signaling antagonist 3 [Gene - OMIM - HGNC]
  • TMLHE:trimethyllysine hydroxylase, epsilon [Gene - OMIM - HGNC]
  • LOC101927830:uncharacterized LOC101927830 [Gene]
  • VAMP7:vesicle associated membrane protein 7 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
Xq28
Genomic location:
ChrX: 154612552 - 156038495 (on Assembly GRCh38)
Preferred name:
NC_000023.11:g.(154612552_154656872)_(156005236_156038495)del
HGVS:
NC_000023.11:g.(154612552_154656872)_(156005236_156038495)del
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002099064New York Genome Center - CSER-NYCKidSeq
criteria provided, single submitter

(NYGC Assertion Criteria 2020)
Pathogenic
(Feb 19, 2021)
de novoclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novounknown1not providednot provided1not providedclinical testing

Details of each submission

From New York Genome Center - CSER-NYCKidSeq, SCV002099064.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

The Xq28 deletion is an approximately ~1.4 MB deletion at the terminal region of the long arm of the X-chromosome. The centromeric breakpoint of this deletion is within a LCR and is poorly mapped with genome sequencing technology. Microarray analysis suggests this deletion has centromeric breakpoint occurring between the L1 and L2 region at the Int22h1 border (see [PMID:29341460] and extending to the telomere of Xq, and does include the Pseudoautosomal Region 2 (PAR2) of the X chromosome. This region contains approximately 55 genes, 19 of which are OMIM associated. Several of these genes are associated with X-linked conditions including DKC1 (Dyskeratosis congenita X-Linked; MIM#305000), F8 (Hemophilia A; MIM#306700), RAB39B (Intellectual Disability, X-Linked 72; MIM#300271 and Waisman syndrome; MIM#311510), CLIC2 (?Intellectual Disability, X-Linked, syndromic 32; MIM#300886), and TMLHE ({Autism, susceptibility to, X-linked 6}; MIM#300872). Loss of each of these genes, or deletion in this region, is linked to disorders primarily affecting males, with females largely being asymptomatic. However, mildly affected females and phenotypic variability in females has also been rarely reported [PMID:27570172, 33082527, Family 6-PMID:25927380, others] and possibly corresponds to skewing of X-chromosome inactivation in those individuals. This variant was detected de novo in an individual submitted for clinical testing. The de novo Xq28 deletion is reported as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novounknown1not providednot provided1not providednot providednot provided

Last Updated: Oct 14, 2023